EDISON, N.J., Nov. 29 /PRNewswire-FirstCall/ -- New Brunswick Scientific Co., Inc. (NBS) , today announced the roll-out of its Innova(R) CO-14 micro CO2 incubator, the latest in NBS’ line of CO2 Incubators, all featuring six-sided direct heat to optimize temperature control while minimizing bench space, fanless chamber convection and a large display with intuitive controls to simplify operation.
New Brunswick Scientific President and Chief Operating Officer James Orcutt commented, “The Innova CO-14 is ideally suited to in-vitro fertilization needs as well as any cell culture work requiring isolation of sensitive samples. At less than 13 inches wide, the compact and efficient design of this 14 liter-capacity CO2 incubator enables single or stacked placement, thereby occupying an exceptionally small footprint.
“NBS’ line of state-of-the-art CO2 incubators, sold worldwide to life science and biotech research customers in more than 40 countries, continues to contribute meaningfully to consolidated revenues. Today’s announcement represents yet another in a series of new-product launches during the current year resulting from our sustained commitment to strategic investment in research and development,” Orcutt concluded.
To be added to New Brunswick Scientific’s e-mail distribution list, please click on the link below:
http://www.clearperspectivegroup.com/clearsite/nbsc/emailoptin.html
About New Brunswick Scientific
New Brunswick Scientific Co., Inc., is a leading global provider of a comprehensive line of research equipment and scientific instrumentation for use in the life science industry. The Company’s products are used in the creation, maintenance and control of physical and biochemical environments required for the growth, detection and storage of microorganisms for medical, biological and chemical applications, as well as environmental research and commercial product development. NBS is a forerunner in the research and development of pioneering equipment to meet the challenges of new areas of advancement in life science. Established in 1946, New Brunswick Scientific is headquartered in Edison, New Jersey, with sales and distribution facilities strategically located in the United States, Europe and Asia. For more information, please visit http://www.nbsc.com .
This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates,” “will” or words of similar meaning and include, but are not limited to, statements about the expected future business and financial performance of the Company. The forward-looking statements involve a number of risks and uncertainties, including but not limited to, changes in economic conditions, demand for the Company’s products, pricing pressures, intense competition in the industries in which the Company operates, the need for the Company to keep pace with technological developments and respond in a timely manner to changes in customer needs, the Company’s dependence on third-party suppliers, the effect on foreign sales of currency fluctuations, acceptance of new products, the labor relations of the Company and its customers and other factors identified in the Company’s Securities and Exchange Commission filings. Forward-looking statements are based on management’s current expectations and assumptions, which are inherently subject to uncertainties, risks and changes in circumstances that are difficult to predict. Actual outcomes and results may differ materially from these expectations and assumptions due to changes in global political, economic, business, competitive, market, regulatory and other factors. The Company undertakes no obligation to publicly update or review any forward-looking information, whether as a result of new information, future developments or otherwise.
New Brunswick Scientific Co., Inc.
CONTACT: Samuel Eichenbaum, Vice President, Finance and Treasurer of NewBrunswick Scientific Co., Inc., +1-732-650-2500, same@nbsc.com; or MatthewJ. Dennis, CFA, NBS Investor Relations, Clear Perspective Group, LLC,+1-440-353-0552, mdennis@cpg-llc.com
Web site: http://www.nbsc.com/
